Order Article Reprints

de Jong W, Leal L, Buyze J, Pannus P, Guardo A, Salgado M, Mothe B, Molto J, Moron-Lopez S, Gálvez C, et al. Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix. Vaccines. 2019; 7(4):209. https://doi.org/10.3390/vaccines7040209

de Jong, Wesley, Lorna Leal, Jozefien Buyze, Pieter Pannus, Alberto Guardo, Maria Salgado, Beatriz Mothe, Jose Molto, Sara Moron-Lopez, Cristina Gálvez, and et al. 2019. "Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix" Vaccines 7, no. 4: 209. https://doi.org/10.3390/vaccines7040209

de Jong, W., Leal, L., Buyze, J., Pannus, P., Guardo, A., Salgado, M., Mothe, B., Molto, J., Moron-Lopez, S., Gálvez, C., Florence, E., Vanham, G., van Gorp, E., Brander, C., Allard, S., Thielemans, K., Martinez-Picado, J., Plana, M., García, F., & Gruters, R. A. (2019). Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix. Vaccines, 7(4), 209. https://doi.org/10.3390/vaccines7040209